David W. Denning

David W. Denning

100 connections

Consumer Services

Electronic Technology

Health Technology

Career history of David W. Denning

Former positions of David W. Denning

Companies	Position	Start	End
Stanford University	Corporate Officer/Principal	1986-12-31	1989-12-31
The University of Manchester	Corporate Officer/Principal	1989-12-31	-
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.	Director/Board Member	1997-12-31	-
	Founder	1997-12-31	-
Myconostica Ltd. Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom.	Director/Board Member	2009-09-13	-
	Chairman	-	2009-09-13
	Chief Tech/Sci/R&D Officer	2009-09-13	-
	Founder	2009-09-13	-

Statistics

International

United Kingdom	3
United States	2
Israel	2

Operational

Director/Board Member	2
Founder	2
Corporate Officer/Principal	2

Sectoral

Consumer Services	3
Electronic Technology	2
Health Technology	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Private companies

2

Electronic Technology

Health Technology

See company connections

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer